Welcome to Nightingale Health's investor pages
On our investor pages, you can read about Nightingale Health as an investment, find our latest releases and reports as well as follow Nightingale Health's share price development.
About Nightingale Health
Nightingale Health’s mission is to build sustainable healthcare and reduce health inequalities. Nightingale Health has developed the world’s most advanced health check for the health industry. Our solution provides risk detection for multiple chronic diseases from a single blood sample.
Nightingale Health Check can be scaled to entire populations at a low cost, and it can replace many of the current risk assessments. Detecting disease risks on a population level allows for the effective targeting and tracking of health interventions, and better prevention of the onset of chronic diseases.
Contact us
ir@nightingalehealth.com
Latest releases
Nightingale Health’s Annual Report for financial year 2024–2025 has been published
Nightingale Health Plc Financial Statements Release 1 July 2024 – 30 June 2025
Inside information: Nightingale Health selected as multiomics provider for EUR 2.4 million research project
Conversion of Nightingale Health Plc’s EMP shares to Series B shares
Inside information, profit warning: Nightingale Health’s revenue increases, and adjusted EBITDA declines compared to the previous financial year
Nightingale Health strengthens its commercial operations with new EMEA appointment
Nightingale Health’s management team members Minja Salmio and Satu Saksman recognized for outstanding leadership
Nightingale Health’s Board of Directors resolved on new stock option program
Conversion of Nightingale Health Plc’s Series A shares to Series B shares
Subscribe to releases.
Get the latest Nightingale Health releases delivered straight to your inbox.